Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cance...
Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
About this item
Full title
Author / Creator
Tang, Bo , Li, Yang , Qi, Guangying , Yuan, Shengguang , Wang, Zhenran , Yu, Shuiping , Li, Bo and He, Songqing
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
The prognosis of pancreatic cancer patients is very poor, with a 5-year survival of less than 6%. Previous studies demonstrated that the loss of function of CDKN2A is mainly caused by the hypermethylation of
CDKN2A
gene promoter; however, whether or not it is associated with the incidence of pancreatic cancer still remains unclear. In this st...
Alternative Titles
Full title
Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4642558
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4642558
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/srep13563
